CALLAN JMB INC.
Business
Callan JMB is a vertically integrated logistics and fulfillment company providing thermal management solutions to the life sciences industry through proprietary packaging, information technology, and cold chain logistics expertise. The company offers specialty temperature-regulating reusable packaging, emergency preparedness and response services, fulfillment capabilities, and advanced Sentry monitoring technology for temperature-sensitive shipments. Solutions serve markets including personalized medicine, cell therapies, vaccines, diagnostics, and bio-pharmaceuticals across North America and internationally.
Summary from 10-K filed 2026-03-31
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Revenue | 6 | 7 | 13 | |
| Cost of revenue | 4 | 4 | 8 | |
| Gross profit | 2 | 3 | 6 | |
| Selling, general and administrative expenses | 9 | 5 | 3 | |
| Impairment loss on property and equipment | 542,088 | — | — | |
| Loss from operations | −7 | −2 | 2 | |
| Interest income | 8,691 | 11,904 | — | |
| Interest expense | −2,675 | −5,372 | −8,131 | |
| ELOC facility transaction expenses | −569,552 | — | — | |
| Changes in fair value of derivative liability (see Note 8) | −371,216 | — | — | |
| Total other income (expenses) | −934,752 | 6,532 | 2,045 | |
| Loss before income taxes | −8 | −2 | 2 | |
| Provision (benefit) for income taxes | −2,965 | 25,366 | 23,000 | |
| Net loss | −8 | −2 | 2 | |
| Weighted average common shares outstanding - basic | 4 | 3 | — | |
| Weighted average common shares outstanding - diluted | 4 | 3 | — | |
| Net loss per common share - basic | −1.82 | −0.87 | — | |
| Net loss per common share - diluted | −1.82 | −0.87 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2025 2025-02-28 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2 | — | 2 | 5 | — | |
| Accounts receivable, net of allowance for credit losses of $61,675 and $64,000, respectively | 343,246 | — | 622,914 | 3 | — | |
| Inventory | 243,285 | — | 158,362 | 114,739 | — | |
| Related party loans | — | — | 18,669 | 21,969 | — | |
| Tax refund receivable | — | — | 6,377 | — | — | |
| Other current assets | 341,311 | — | 278,896 | 235,987 | — | |
| Deferred offering costs | — | 188,832 | 136,025 | 25,000 | — | |
| Total current assets | 3 | — | 3 | 8 | — | |
| Right of use assets operating lease | 2 | — | 883,029 | 275,208 | — | |
| Property and equipment, net of accumulated depreciation of $760,655 and $608,703, respectively | 799,538 | — | 876,682 | 974,206 | — | |
| Security deposit | — | — | 3,650 | 3,650 | — | |
| Total assets | 6 | — | 5 | 10 | — | |
| Accounts payable | 564,014 | — | 371,661 | — | — | |
| Accrued expenses | 502,183 | — | 506,381 | — | — | |
| Corporate taxes payable | 23,085 | — | 23,000 | 67,000 | — | |
| Deferred revenue | — | — | 94,097 | 12,113 | — | |
| Right of use liability operating lease | 323,935 | — | 279,176 | 151,627 | — | |
| Total current liabilities | 1 | — | 1 | 769,706 | — | |
| Right of use liability operating lease | 2 | — | 628,274 | 132,488 | — | |
| Derivative liability | 371,216 | — | — | — | — | |
| Deferred tax liabilities | — | — | 6,602 | — | — | |
| Total long-term liabilities | 2 | — | 634,876 | 140,563 | — | |
| Total liabilities | 3 | — | 2 | 910,269 | — | |
| Commitments and contingencies Note 7 | — | — | — | — | — | |
| Preferred stock - authorized 10,000,000 shares, $0.001 par value; zero issued and outstanding as of December 31, 2025 and December 31, 2024 | — | — | — | — | — | |
| Common stock - authorized 190,000,000 shares, par value $0.001 par value; 4,858,663 issued and outstanding as of December 31, 2025 and 3,000,000 December 31, 2024 | 4,860 | — | 3,000 | — | — | |
| Additional paid in capital | 13 | — | 5 | — | — | |
| Accumulated deficit | −10 | — | −2 | — | — | |
| Total stockholders equity | 2 | — | 3 | 9 | 14 | |
| Total liabilities and stockholders equity | 6 | — | 5 | 10 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Provision (Recovery) for credit losses | 230,190 | −131,000 | 277,000 | |
| Depreciation and amortization | 151,952 | 143,691 | — | |
| Other non-cash expenses relating to ELOC Facility | 519,552 | — | — | |
| Stock based compensation | 2 | — | — | |
| Impairment loss on property and equipment | 542,088 | — | — | |
| Accounts receivable | 49,478 | 2 | 5 | |
| Inventory | −84,923 | −43,623 | −35,294 | |
| Tax refund receivable | 6,377 | −6,377 | — | |
| Other current assets | −58,765 | −42,909 | 115,630 | |
| Operating lease liabilities | 45,180 | 15,514 | −817 | |
| Accounts payable and accrued expenses | 188,155 | 461,958 | −251,542 | |
| Deferred revenue | −94,097 | 73,909 | 20,188 | |
| Corporate taxes payable | 85 | −44,000 | −43,000 | |
| Deferred tax liabilities | −6,602 | −398 | — | |
| Net cash provided by (used in) operating activities | −5 | 540,353 | 7 | |
| Purchase of property and equipment | −616,896 | −46,167 | −490,020 | |
| Net cash used in investing activity | −616,896 | −46,167 | −490,020 | |
| Related party receivable | — | 3,300 | — | |
| Related party loans | 18,669 | −17,073 | −5,337 | |
| Deferred offering costs | 136,025 | −111,025 | — | |
| Partner distributions | — | −3 | −7 | |
| Net change note payable | — | −98,809 | −133,565 | |
| Proceeds from IPO and overallotment, net | 5 | — | — | |
| Proceeds from offering of ELOC shares | 497,750 | — | — | |
| Net cash provided by (used in) financing activities | 5 | −4 | −8 | |
| Increase (decrease) in cash and cash equivalents | 32,813 | −3 | −1 | |
| Cash paid for interest | 2,675 | 5,372 | 8,131 | |
| Initial recognition of derivative liability | 974,309 | — | — | |
| Right of use assets acquired and corresponding operating lease liability | 708,321 | — | — | |
| Right-of-use assets and corresponding lease liabilities due to lease modifications | 628,407 | 900,133 | — | |
| Reduction in allowance for credit losses | — | 163,000 | — | |
| Membership exchange for common stock | — | 5 | — | |
| Fair value of Stock Warrants issued at IPO | 144,358 | — | — | |
| Deferred offering costs charged to additional paid-in-capital | 136,025 | — | — | |
| Par value of shares issued for restricted stock award units vesting | 75 | — | — | |
| Commitment shares adjustment to APIC | 78,000 | — | — | |
| Other non-cash ELOC expenses | 441,552 | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is CALLAN JMB INC.'s CIK number?
CALLAN JMB INC.'s SEC CIK number is 0002032545 (2032545). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find CALLAN JMB INC.'s SEC filings?
All of CALLAN JMB INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did CALLAN JMB INC. last report earnings?
CALLAN JMB INC. (CJMB) most recently filed an earnings 8-K with the SEC on Mar 31, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001493152-26-014140). This is CALLAN JMB INC.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is CALLAN JMB INC.'s most recent earnings 8-K?
CALLAN JMB INC.'s latest earnings 8-K (Item 2.02) was filed Mar 31, 2026 under accession 0001493152-26-014140. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View CALLAN JMB INC.'s latest earnings 8-K →
Look up any company's CIK number →